Latest Headlines
Nov 9
2020
In a new study, Packard researcher Jiou Wang and colleagues have identified a new regulatory switch for protein quality control that plays a role in the development of ALS.
Click here to read the full study:
Oct 16
2020
The Packard Center welcomed Maya Capelson from the University of Pennsylvania to a recent Investigator's meeting.
Oct 16
2020
The Packard Center welcomed Bill Seeley from the University of California San Francisco to a recent Investigator's meeting.
Sep 14
2020
In a new study, a team of Packard scientists identified a key intersection between two major pathways of pathology in ALS and frontotemporal dementia (FTD)
Read the full article in Science Translational Medicine
Sep 11
2020
The Packard Center welcomed Laura Ranum from the University of Florida to a recent Investigator's meeting
Sep 11
2020
The Packard Center welcomed Michael Coleman from the University of Cambridge and Ahmet Hoke from Johns Hopkins University to a recent Investigator's meeting
Sep 3
2020
Results of a new Phase 2 randomized clinical trial in 137 patients with ALS showed that treatment with the drugs sodium phenylbutyrate and taurursodiol, combined together, could significantly slow functional decline over 24 weeks compared to placebo.
Read more about the trial in a recent article on www.nytimes.com
Aug 14
2020
The Packard Center welcomed Alyssa Coyne, PHD from Johns Hopkins University to a recent Investigator's meeting.
Aug 14
2020
The Packard Center welcomed Adrian Isaacs, PHD from University College London to a recent Investigator's meeting.
Jul 23
2020
Packard scientist Mervyn Monteiro showed that ALS-linked mutations in UBQLN2 interferes with autophagy by blocking an acidification step critical for the process.
